• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

2-{1-2-(1H-pyrazol-1-yl)ethylcyclopropyl}acetic acid (CAS No. 2229571-47-3): A Comprehensive Overview

2-{1-2-(1H-pyrazol-1-yl)ethylcyclopropyl}acetic acid (CAS No. 2229571-47-3) is a novel compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, holds potential applications in various therapeutic areas, particularly in the development of new drugs targeting specific biological pathways. This article provides a detailed overview of the chemical properties, synthesis methods, biological activities, and recent research advancements related to 2-{1-2-(1H-pyrazol-1-yl)ethylcyclopropyl}acetic acid.

Chemical Structure and Properties

2-{1-2-(1H-pyrazol-1-yl)ethylcyclopropyl}acetic acid is a member of the acetic acid derivatives with a distinctive cyclopropyl and pyrazole moiety. The cyclopropyl ring imparts rigidity to the molecule, which can influence its conformational flexibility and binding properties. The pyrazole group, known for its bioisosteric properties, contributes to the compound's pharmacological activity by enhancing its interaction with biological targets. The molecular formula of 2-{1-2-(1H-pyrazol-1-yl)ethylcyclopropyl}acetic acid is C₁₃H₁₆N₂O₂, and its molecular weight is approximately 236.3 g/mol.

The compound exhibits good solubility in polar solvents such as methanol and dimethyl sulfoxide (DMSO), making it suitable for various biochemical assays and drug delivery systems. Its physical properties, including melting point and boiling point, are currently under investigation to better understand its behavior in different environments.

Synthesis Methods

The synthesis of 2-{1-2-(1H-pyrazol-1-yl)ethylcyclopropyl}acetic acid has been explored through several routes, each offering unique advantages and challenges. One common approach involves the reaction of a cyclopropylcarbinol derivative with a pyrazole-containing reagent followed by an acetylation step. This method typically yields high purity products but may require rigorous purification techniques to remove by-products.

An alternative synthetic pathway involves the use of transition metal-catalyzed cross-coupling reactions, such as Suzuki-Miyaura coupling or Stille coupling, to construct the cyclopropyl and pyrazole moieties in a single step. These methods are highly efficient and can be optimized for large-scale production, making them attractive for industrial applications.

Biological Activities and Mechanisms of Action

2-{1-2-(1H-pyrazol-1-yl)ethylcyclopropyl}acetic acid has shown promising biological activities in various preclinical studies. One of its key properties is its ability to modulate specific enzymes involved in metabolic pathways. For instance, it has been reported to inhibit certain isoforms of cyclooxygenase (COX), which are implicated in inflammation and pain. This makes it a potential candidate for the development of anti-inflammatory drugs with reduced side effects compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs).

In addition to its anti-inflammatory effects, 2-{1-2-(1H-pyrazol-1-yl)ethylcyclopropyl}acetic acid has demonstrated activity against certain types of cancer cells. Studies have shown that it can induce apoptosis in cancer cells by disrupting mitochondrial function and activating caspase-dependent pathways. These findings suggest that the compound may have therapeutic potential in oncology.

Clinical Applications and Research Advancements

The potential clinical applications of 2-{1-2-(1H-pyrazol-1-yl)ethylcyclopropyl}acetic acid are being actively investigated through preclinical and early-stage clinical trials. Initial studies have focused on its use as an anti-inflammatory agent for conditions such as osteoarthritis and rheumatoid arthritis. The results have been encouraging, with the compound showing significant efficacy in reducing inflammation without causing severe side effects.

In the field of oncology, researchers are exploring the use of 2-{1-2-(1H-pyrazol-1-yl)ethylcyclopropyl}acetic acid as a targeted therapy for specific types of cancer. Preclinical studies have demonstrated its ability to selectively target cancer cells while sparing normal tissues, which could lead to more effective and safer treatments.

Conclusion

2-{1-2-(1H-pyrazol-1-yl)ethylcyclopropyl}acetic acid (CAS No. 2229571-47-3) is a promising compound with diverse biological activities and potential therapeutic applications. Its unique chemical structure, coupled with its favorable biological properties, makes it an attractive candidate for further research and development in medicinal chemistry and pharmaceutical sciences. As ongoing studies continue to uncover new insights into its mechanisms of action and clinical efficacy, this compound is poised to play a significant role in advancing our understanding and treatment of various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)